SERPINC1, also called antithrombin III, is the main inhibitor of blood coagulation which can attenuate inflammatory responses.23 Collectively, our analysis indicates that development of CRC causes plasma protein changes which are associated with complement cascade and cholesterol metabolism. The gene discussed is SERPINC1; the disease is colorectal carcinoma.